Science News: Late-Breaking Oral Abstracts and More

International Stroke Conference 2016

Sessions: Feb. 17-19, 2016
Los Angeles Convention Center | Los Angeles, CA

Selected Science from Wednesday, February 17

Acute Endovascular Treatment Oral Abstracts I - Wednesday, 7:00 - 8:30 a.m.

 
Thrace Study: Final Results
Serge Bracard | University of Lorraine, Nancy, France
Plenary Session I - Wednesday, 10:30 - 12:00 p.m.

 
LB1 - Main Results of the Insulin Resistance Intervention After Stroke (IRIS) Trial
Walter N Kernan | Yale School of Medicine, New Haven, CT

 
LB2 - Finding Atrial Fibrillation In Stroke Patients - A Multicenter Randomised Evaluation Of Enhanced And Prolonged Holter Monitoring (Find-AFrandomised- Trial)
Rolf Wachter | University of Goettingen, Göttingen, Germany

 
LB25 - Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis: Initial and Five-year Results of the ACT 1 Trial
Lawrence R Wechsler | University of Pittsburgh School of Medicine, Pittsburgh, PA
Late-Breaking Science Oral Abstracts I - Wednesday, 3:30 - 5:30 p.m.
  LB3 - ARTSS-2: Final Results of a Pilot, Phase IIb, Randomized, Multi-center Trial of Argatroban in Combination With Recombinant Tissue Plasminogen Activator for Acute Stroke
Andrew Barreto | University of Texas Health Science Center at Houston, Houston, TX
 
 
LB4 - ICTuS-2 Final Results
Patrick Lyden | Cedars-Sinai Medical Center, Los Angeles, CA
 
 
LB5 - High-dose Statin Therapy After Acute Ischemic Stroke: The Phase 2 Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART)
Mitchell S Elkind | Columbia University, New York, NY

 
LB6 - GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP: A Phase II Study Toward Preventing Edema After Ischemia
Kevin N Sheth | Yale University, New Haven, CT

 
LB8 - Virtual Reality in Stroke Rehabilitation: Results From EVREST Multicenter Trial
Gustavo Saposnik | Center for Virtual Reality Studies, St Michael's Hospital, University of Toronto, Toronto, ON, Canada
 
 
LB9 - Results of the Pragmatic Ischaemic Thrombectomy Evaluation (PISTE) Trial
Keith W Muir | University of Glasgow, Glasgow, United Kingdom

Selected Science from Thursday, February 18

Plenary Session II - Thursday, 10:30 - 12:00 p.m.

 
LB10 - Carotid Endarterectomy versus Stenting for Treatment of Carotid Artery Stenosis: Long-term Results of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST)
Thomas G Brott | Mayo Clinic Jacksonville, Jacksonville, FL
 

 
LB11 - A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA): 5-year Results
Christian Stapf, University de Montréal - CRCHUM, Montreal, QC, Canada
  LB12 - Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III) Results
Daniel F Hanley | Johns Hopkins University, Baltimore, MD
LB13 - Efficiency of Intraventricular Hemorrhage Removal Determines Modified Rankin Scale Score (CLEAR III)
Issam A Awad | University of Chicago, Chicago, IL
  LB14 - Randomized Trial on Normalization of International Normalized Ratio Using Prothrombin Complex or Fresh Frozen Plasma in Vitamin-k Related Intracranial Bleeding
Thorsten Steiner | Klinikum Frankfurt Höchst, Frankfurt, Germany
Late Breaking Science Oral Abstracts II - Thursday, 1:30 - 3:00 p.m.
LB15 - Predictors of Intracranial Hemorrhage and Clinical Outcome After Stentriever Thrombectomy: Pooled Analysis From Swift Prime, Swift and Star Trials
Radoslav Raychev | UCLA Stroke Center, Los Angeles, CA
LB17 - Expanding Opportunities for Intravenous Alteplase Treatment of Patients With Unwitnessed Acute Stroke Using MRI-based Patient Selection: Imaging Results of the MR WITNESS Multicenter Trial (NCT01282242)
Ona Wu | Massachusetts General Hospital, Boston, MA
LB18 - Endovascular Treatment in Acute Ischemic Stroke: A Meta-analysis of Individual Patient Data From Mr Clean, Escape, Extend IA, Swift Prime and Revascat
Tudor G Jovin | UPMC Stroke Institute, Pittsburgh, PA
LB19 - MultiStem® Treatment Reduces Length of Hospitalization When Administered Within 36 Hours After Onset of Ischemic Stroke: Implications on Lowering Stroke Related Health Care Costs
Lawrence R. Wechsler | University of Pittsburgh Medical Center, Pittsburgh, PA
LB20 - Validation of a Simplified Eight-item NIHSS to Identify Acute Ischemic Stroke Patients With Large Vessel Occlusion
Jelle Demeestere | John Hunter Hospital, Newcastle, Australia
LB21 - Cost-effectiveness of Solitaire + IV-tPA for Acute Ischemic Stroke: Results From the Swift-Prime Trial
Theresa I Shireman | Brown University, Providence, RI

Selected Science from Friday, February 19

Plenary Session III - Friday, 10:30 - 12:30 p.m.
LB22 - Primary Results of the ACTION Trial of Natalizumab in Acute Ischemic Stroke (AIS)
Jacob Elkins | Biogen, Cambridge, MA
LB23 - IV Alteplase in MR-selected Patients With Stroke of Unknown Onset is Safe and Feasible: Results of the Multicenter MR WITNESS Trial (NCT01282242)
Lee H Schwamm | Massachusetts General Hospital, Boston, MA
LB24 - GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP Trial: Intermediate Endpoint Analysis as Proof-of-Concept
W. Taylor Kimberly | Massachusetts General Hospital, Boston, MA